A Shared Asian Origin of the Triple‐MutantdhfrAllele inPlasmodium falciparumfrom Sites across Africa
Author(s) -
Oumou MaïgaAscofaré,
Abdoulaye Djimdé,
Véronique Hubert,
Emmanuelle Renard,
Agnès Aubouy,
Fred Kironde,
Basile Nsimba,
Kwadwo A. Koram,
Ogobara K. Doumbo,
Jacques Le Bras,
Jérôme Clain
Publication year - 2007
Publication title -
the journal of infectious diseases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.69
H-Index - 252
eISSN - 1537-6613
pISSN - 0022-1899
DOI - 10.1086/518512
Subject(s) - plasmodium falciparum , malaria , pyrimethamine , allele , sulfadoxine/pyrimethamine , haplotype , biology , sulfadoxine , genetics , mutant , virology , immunology , gene
Usefulness of sulfadoxine-pyrimethamine as first-line therapy for uncomplicated Plasmodium falciparum malaria and intermittent preventive treatment in pregnancy throughout sub-Saharan Africa is compromised by the spread of dhfr alleles associated with pyrimethamine resistance. A predominant haplotype associated with the N51I+C59R+S108N triple-mutant dhfr allele has been reported recently in 4 African countries. A more comprehensive picture of the evolution of this mutant allele in Africa is lacking.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom